<DOC>
	<DOCNO>NCT00022165</DOCNO>
	<brief_summary>RATIONALE : Chemoprevention therapy use certain drug try prevent development cancer . Selenium may effective prevent cancer . It yet know dose selenium may effective prevent cancer . PURPOSE : Randomized pilot study determine effectiveness selenium prevent cancer healthy people .</brief_summary>
	<brief_title>Selenium Prevention Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Determine whether daily supplementation selenium significantly reduce total cancer incidence site-specific cancer incidence general population . II . Determine whether regimen beneficial effect mood . OUTLINE : This randomize , double-blind , placebo-controlled , multicenter study . Participants stratify accord age ( 60-64 v 65-69 vs 70-74 ) . Participants randomize one four arm . Arm I : Participants receive oral placebo daily . Arm II : Participants receive low-dose oral selenium daily . Arm III : Participants receive moderate-dose oral selenium daily . Arm IV : Participants receive high-dose oral selenium daily . Treatment arm continue 2 year absence unacceptable side effect diagnosis cancer . PROJECTED ACCRUAL : A total 510 patient ( 170 per stratum ) accrue study within 9-12 month .</detailed_description>
	<mesh_term>Selenium</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Healthy men woman No prior diagnosis cancer except nonmelanoma skin cancer PATIENT CHARACTERISTICS : Age : 60 74 Performance status : SWOG 01 Life expectancy : Not specify Hematopoietic : Not specify Hepatic : No active liver disease No known abnormal liver function Renal : No active kidney disease No known abnormal kidney function Other : HIV negative No diminish mental capacity would preclude study PRIOR CONCURRENT THERAPY : No concurrent selenium supplement ( 50 ug/day )</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>unspecified adult solid tumor , protocol specific</keyword>
</DOC>